World Human Vaccine Market Space Canvassed by Infiniti Research in New Research Report Now Available at MarketPublishers.com
09 Feb 2016 • by Natalie Aster
LONDON – The world human vaccines market is forecast to grow at a CAGR of just under 11.7% through to 2020. The rising awareness of vaccination and immunisation programmes, inclusion of the vaccines in national immunisation schedule, increased demand for paediatric vaccines, and an increase in the prevalence of infections are some of the most essential factors propelling the growth of the sector. The market has also seen an upsurge in strategic alliances and M&As, hike in investments, emergence of new vaccines, advent of resistant strains, etc. Although, inadequate vaccination coverage, vaccine storage and handling issues, high risk related to vaccine development, rigorous regulatory process, incorrect perception of vaccines, and negative side effects of vaccines will likely act as key challenges to the market growth. Merck, GlaxoSmithKline, Pfizer and Sanofi are the dominant players in the market.
Topical market research report “Global Human Vaccine Market 2016-2020” drawn up by Infiniti Research examines the present scenario and outlines the growth prospects of the global human vaccines market to 2020. The study presents detailed market segmentation based on type of human vaccine, composition, and by route of administration. The report provides market sizing and forecasting, as well as includes Porter’s five forces analysis for the market. A geographical market segmentation is provided across the Americas, the APAC region and Europe. The research publication identifies and canvasses the market drivers, hindrances, trends, and challenges. Additionally, an exhaustive assessment of the top vendors in this marketplace is provided.
Global Human Vaccine Market 2016-2020
Date: January, 2016
Price: US$ 3,000.00
More studies by the publisher can be found at Infiniti Research page.